Haemonetics to draw $150 million under revolver to finance acquisition

By Marisa Wong

Los Angeles, April 1 – Haemonetics Corp. drew $150 million under its revolving credit facility to finance, along with cash on hand, its acquisition of Attune Medical, according to a press release.

The acquisition includes an upfront cash payment of $160 million plus additional contingent consideration based on sales growth over the next three years and the achievement of some other milestones.

Following this acquisition, Haemonetics estimates that its net debt to EBITDA ratio will be about 2.4x. The global medical technology company is based in Boston

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.